Cigna Group
CI
View Detailed Chart
271.270USD
-1.110-0.41%
Close 01/29, 16:00（ET）Quotes delayed by 15 min
72.32BMarket Cap
11.91P/E TTM
Intraday
1m
30m
1h
D
W
M
D
Today
-0.41%
5 Days
-3.25%
1 Month
-1.72%
6 Months
-7.15%
Year to Date
-1.44%
1 Year
-10.56%
View Detailed Chart
TradingKey Stock Score of Cigna Group
Currency: USD Updated: 2026-01-28Key Insights
Cigna Group's fundamentals are relatively stable, and its growth potential is high.Its valuation is considered fairly valued, ranking 11 out of 76 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 327.37.In the medium term, the stock price is expected to trend up.Despite an average stock market performance over the past month, the company shows strong fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Cigna Group's Score
Support & Resistance
Relevant data have not been disclosed by the company yet.
Score Analysis
Current score
Previous score
Media Coverage
Last 24 hours
Coverage Level
40°C
Very Low
Very High
Neutral
Cigna Group Highlights
StrengthsRisks
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Industry Leader
The company's revenue leads the industry, with the latest annual revenue totaling USD 247.12B.
High Growth
The company's revenue has grown steadily over the past 3 years, averaging 36.90% year-on-year.
High Dividend
The company is a high dividend payer, with the latest dividend payout ratio of 45.63%.
Stable Dividend
The company has regularly paid dividends over the past 5 years, with the latest dividend payout ratio of 45.63%.
Undervalued
The company’s latest PE is 11.96, at a low 3-year percentile range.
Institutional Buying
The latest institutional holdings are 242.25M shares, increasing 0.07% quarter-over-quarter.
Held by Barrow Hanley
Star Investor Barrow Hanley holds 13.71K shares of this stock.
Analyst Rating
Based on
25
analysts
Buy
Current Rating
327.371
Target Price
+17.25%
Upside Space
Data disclaimer: Analyst ratings and target prices are provided by LSEG for informational purposes only and do not constitute investment advice.
Cigna Group News
More news coming soon, stay tuned...
Financial Indicators
EPS
Relevant data have not been disclosed by the company yet.
Total revenue
Relevant data have not been disclosed by the company yet.
Cigna Group Info
The Cigna Group is a global health company. The Company has two growth platforms: Evernorth Health Services and Cigna Healthcare. Evernorth Health Services includes its Pharmacy Benefit Services and Specialty and Care Services operating segments, which provide independent and coordinated health solutions and capabilities to enable the healthcare system to work better and help people live richer, healthier lives. Cigna Healthcare includes the U.S. Healthcare and International Health operating segments, which provide comprehensive medical plan services and coordinated solutions to clients and customers. Its Other Operations include corporate-owned life insurance (COLI), the Company's run-off operations and other non-strategic businesses. Specialty and Care Services provides specialty drugs for the treatment of complex and rare diseases, specialty distribution of pharmaceuticals and medical supplies, and clinical programs to help its clients.
Ticker SymbolCI
CompanyCigna Group
CEOCordani (David M)
Websitehttps://www.thecignagroup.com/
Related Instruments
-0.59%
-2.61%
+0.04%
-2.78%
-2.19%
-1.56%
-0.99%
+0.21%
-1.77%
+0.55%
+1.50%
+0.45%
-1.33%
-0.41%
-1.60%
-0.45%
+0.91%
-0.45%
-0.04%Popular Symbols
258.280
+1.840 (+0.72%)
192.510
+0.990 (+0.52%)
83850.030
-328.920 (-0.39%)
278.410
-1.290 (-0.46%)
2803.030
-0.320 (-0.01%)
416.560
-14.900 (-3.45%)
5352.550
-41.050 (-0.76%)
64.814
-0.424 (-0.65%)
1.193
-0.003 (-0.28%)
153.589
+0.477 (+0.31%)
